Diagnostic criteria for ductal adenocarcinoma of the prostate. Interobserver variability among 20 expert uropathologists
Amanda H. Seipel(Karolinska Institutet), Lars Egevad(Karolinska Institutet), C. Magi-Galluzzi, David J. Grignon(Indiana University School of Medicine), Kiril Trpkov(University of Calgary), Samson W. Fine(Memorial Sloan Kettering Cancer Center), Brett Delahunt(Malaghan Institute of Medical Research), Hemamali Samaratunga(The University of Queensland), Athanase Billis(Universidade Estadual de Campinas (UNICAMP)), Amar Ahmad(Cancer Research UK), Rodolfo Montironi(Marche Polytechnic University), Theodorus van der Kwast(Erasmus MC), Peter A. Humphrey(Jewish Hospital), Angela D. Evans, Daniel M. Berney(Queen Mary University of London), Lionel Tim‐Ee Cheng, Ming Zhou(Indiana University School of Medicine), Mitual Amin(Oakland University), Mala Varma, John R. Srigley(University of Toronto), E. Compérat, S Moss, Sesterhenn Ia, Jan Bartoň
Queensland's institutional digital repository (The University of Queensland)
January 1, 2014
Cited by 0
Related Papers
The Banff 97 working classification of renal allograft pathology
|Kidney International|1999|3.1k
Antibody-Mediated Rejection Criteria - an Addition to the Banff ’97 Classification of Renal Allograft Rejection
|American Journal of Transplantation|2003|1.1k
External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study
|The Lancet Oncology|2010|944
Classification of renal cell carcinoma
|Cancer|1997|878
The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on Grading of Prostatic Carcinoma
|The American Journal of Surgical Pathology|2020|705